Blog Information

• Posted By : oncology cro
• Posted On : Aug 20, 2022
• Views : 261
• Category : General
• Description : Small or niche contract research organization focus their resources and energies on therapeutic areas and geography to develop in-depth expertise and current knowledge that contribute to the successful completion of clinical trials.

Overview

• These small Contract research organization also build relationships with investigators and research sites. Taking a step further, Vial established a Site Network that it leverages to provide sponsors with faster, higher-quality trial outcomes that translate to improved project timelines and reduced costs. To date, there are over 35 clinical research sites in the Vial Site Network.
  
  

  Therapy Experience : Sponsors have a preference for Contract research organization with experience in their targeted therapeutic area(s) and who understand the challenges they will encounter on the path to regulatory approval.
  
  Smaller biopharma companies embarking on drug development for the first time may rely on Contract research organization partners like Vial and its expertise in therapeutic areas, to supplement its own capabilities, and to provide tactical and strategic support. 
  
  

  Technology : Small CROs with expertise in niche areas are poised to adopt the latest technologies, identify opportunities for application, and provide insights on how the tech may be deployed to improve clinical trial performance. To this end, some CROs have developed their own unique technology products and services.
  
  
  
                              
  
  
  
  The Vial clinical trial management system (CTMS), VialConnect is one such example of tech-enabled clinical trials supported by a small Contract research organization. For more information on the tech-enabled capabilities developed by Vial, click on the links below: 

  Small CROs are flexible, adopt the latest in technology and are able to customize solutions to meet the needs of sponsors, regardless of their size. Cognizant of the growth in demand for clinical trials by emerging biopharma companies and their unique clinical research needs, small niche CROs also have the experience, expertise, and focus to be valuable partners in their drug development journeys.